Integrating Transcriptomic Data with Mechanistic Systems Pharmacology Models for Virtual Drug Combination Trials.

about

Analysis of copy number loss of the ErbB4 receptor tyrosine kinase in glioblastoma.Spatiotemporal switching signals for cancer stem cell activation in pediatric origins of adulthood cancer: Towards a watch-and-wait lifetime strategy for cancer treatment.

P2860

Q47860000-0CDD4FD8-0D64-465E-8D67-E329AC249DF9 Q52659313-CA1E7361-EE48-42D9-9B79-A7532CF905BC

P2860

Integrating Transcriptomic Data with Mechanistic Systems Pharmacology Models for Virtual Drug Combination Trials.

Item

http://www.wikidata.org/entity/Q47630528

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Integrating Transcriptomic Dat ...... rtual Drug Combination Trials.

@en

Integrating Transcriptomic Dat ...... rtual Drug Combination Trials.

@nl

type

Item

label

Integrating Transcriptomic Dat ...... rtual Drug Combination Trials.

@en

Integrating Transcriptomic Dat ...... rtual Drug Combination Trials.

@nl

prefLabel

Integrating Transcriptomic Dat ...... rtual Drug Combination Trials.

@en

Integrating Transcriptomic Dat ...... rtual Drug Combination Trials.

@nl

P1476

Integrating Transcriptomic Dat ...... irtual Drug Combination Trials

@en

P2093

Marc R Birtwistle

http://www.w3.org/2001/XMLSchema#string

Mehdi Bouhaddou

http://www.w3.org/2001/XMLSchema#string

P2860

Mutational profiling of kinases in glioblastoma.

Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation

Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

Structural mechanism for STI-571 inhibition of abelson tyrosine kinase

RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth

CDK 4/6 inhibitors sensitize PIK3CA mutant breast cancer to PI3K inhibitors.

Improved overall survival in melanoma with combined dabrafenib and trametinib.

The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study.

P304

118-129

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/ACSCHEMNEURO.7B00197

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Anne Marie Barrette

P577

2017-10-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28950062

http://www.w3.org/2001/XMLSchema#string

P921

Farmakologi

transcriptome

P932

5771884

http://www.w3.org/2001/XMLSchema#string

Integrating Transcriptomic Data with Mechanistic Systems Pharmacology Models for Virtual Drug Combination Trials.

about

P2860

P2860

Integrating Transcriptomic Data with Mechanistic Systems Pharmacology Models for Virtual Drug Combination Trials.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932